160 related articles for article (PubMed ID: 9816333)
1. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
Emadian SM; McDonald JD; Gerken SC; Fults D
Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
Pietsch T; Koch A; Wiestler OD
Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
[TBL] [Abstract][Full Text] [Related]
4. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.
Schofield D; West DC; Anthony DC; Marshal R; Sklar J
Am J Pathol; 1995 Feb; 146(2):472-80. PubMed ID: 7856756
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.
Thomas GA; Raffel C
Cancer Res; 1991 Jan; 51(2):639-43. PubMed ID: 1670763
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping on chromosome 17p in medulloblastoma.
Steichen-Gersdorf E; Baumgartner M; Kreczy A; Maier H; Fink FM
Br J Cancer; 1997; 76(10):1284-7. PubMed ID: 9374372
[TBL] [Abstract][Full Text] [Related]
9. No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor (medulloblastoma).
Biegel JA; Wentz E
Genes Chromosomes Cancer; 1997 Feb; 18(2):143-6. PubMed ID: 9115964
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
Rood BR; Zhang H; Weitman DM; Cogen PH
Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma.
Kraus JA; Koch A; Albrecht S; Von Deimling A; Wiestler OD; Pietsch T
Int J Cancer; 1996 Jul; 67(1):11-5. PubMed ID: 8690510
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity and p53 polymorphism Pro72Arg in a young patient with medulloblastoma.
Sardi I; Giunti L; Donati P; Lacitignola L; Tucci F; Sardo L; Giovannucci Uzielli ML; Bernini G
Oncol Rep; 2003; 10(3):773-5. PubMed ID: 12684657
[TBL] [Abstract][Full Text] [Related]
13. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
Raffel C; Gilles FE; Weinberg KI
Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
[TBL] [Abstract][Full Text] [Related]
14. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs.
Frühwald MC; O'Dorisio MS; Dai Z; Rush LJ; Krahe R; Smiraglia DJ; Pietsch T; Elsea SH; Plass C
Genes Chromosomes Cancer; 2001 Jan; 30(1):38-47. PubMed ID: 11107174
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.
Biegel JA; Burk CD; Barr FG; Emanuel BS
Cancer Res; 1992 Jun; 52(12):3391-5. PubMed ID: 1596898
[TBL] [Abstract][Full Text] [Related]
16. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
